1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Biologics Development
  6.  » R&D Leadership During the Pandemic

R&D Leadership During the Pandemic

Summary: Top R&D execs discuss how they’ve reorganized global teams, tapped new programs as a priority to fight COVID-19 and plan for the future after the pandemic has passed.  View this fireside chat with Endpoints Founder John Carroll and Laurie H. Glimcher, President and CEO of the Dana-Farber Cancer Institute followed by a panel discussion from leaders at GlaxoSmithKline, Takeda, Amgen, Johnson & Johnson and Catalent’s Chair & CEO, John Chiminski.

Click here to view the webinar